We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
-9.96%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.8M
AUM Growth
-$83.2M
Cap. Flow
-$71.1M
Cap. Flow %
-99.06%
Top 10 Hldgs %
100%
Holding
13
New
2
Increased
–
Reduced
1
Closed
7

Top Buys

Rank Stock Value
1
XLO icon
Xilio Therapeutics
XLO
+$11.4M
2
RLYB icon
Rallybio
RLYB
+$11M

Top Sells

Rank Stock Value
1
AVIR icon
Atea Pharmaceuticals
AVIR
+$57.4M
2
APLS
Apellis Pharmaceuticals
APLS
+$20.6M
3
KYMR icon
Kymera Therapeutics
KYMR
+$10.6M
4
CLSD
Clearside Biomedical
CLSD
+$1.76M
5
MTEM
Molecular Templates, Inc.
MTEM
+$1.37M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
1
Kymera Therapeutics
KYMR
$8.94B
$29M 40.43%
457,059
-182,000
-28% -$10.6M
SEER icon
2
Seer Inc
SEER
$120M
$18.6M 25.94%
816,375
– –
XLO icon
3
Xilio Therapeutics
XLO
$60.3M
$10.7M 14.88%
+47,696
New +$11.4M
RLYB icon
4
Rallybio
RLYB
$85.8M
$7.2M 10.03%
+94,335
New +$11M
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$3.65M 5.09%
12,438
– –
STRO icon
6
Sutro Biopharma
STRO
$421M
$2.6M 3.63%
17,500
– –
APLS
7
DELISTED
Apellis Pharmaceuticals
APLS
– –
-624,962
Closed -$20.6M
AVIR icon
8
Atea Pharmaceuticals
AVIR
$420M
– –
-1,637,331
Closed -$57.4M
CLSD
9
DELISTED
Clearside Biomedical
CLSD
– –
-19,570
Closed -$1.76M
KZR
10
DELISTED
Kezar Life Sciences
KZR
– –
-12,892
Closed -$1.11M
RNTX
11
Rein Therapeutics
RNTX
$69.9M
– –
-25,878
Closed -$528K
MTEM
12
DELISTED
Molecular Templates, Inc.
MTEM
– –
-13,654
Closed -$1.37M
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-25,651
Closed -$75K

Similar funds

LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
OGC
One68 Global Capital New York $30.9M AUM
AC
ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return
PL
Protective Life Birmingham, Alabama $30.1M AUM 0.65% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return

AJU IB Investment Company's Q4 2021 Portfolio in Review

As of Q4 2021, AJU IB Investment Company held 13 positions worth $71.8M, down 54% from $155M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AJU IB Investment Company withdrew a net $71.1M in Q4 2021, closing 7 positions and reducing 1 holding. Its most notable exit was Atea Pharmaceuticals, an estimated $57.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, AJU IB Investment Company opened a new position in Xilio Therapeutics worth $10.7M.

  • AJU IB Investment Company's largest Q4 2021 buy was Xilio Therapeutics: 47,696 shares worth $10.7M.
  • AJU IB Investment Company's biggest Q4 2021 reduction was Kymera Therapeutics, cutting an estimated $10.6M.
  • AJU IB Investment Company fully exited Atea Pharmaceuticals in Q4 2021, selling an estimated $57.4M.
  • AJU IB Investment Company's ten largest holdings make up 100% of its $71.8M portfolio in Q4 2021.
  • AJU IB Investment Company opened 2 new positions and closed 7 in Q4 2021.
  • AJU IB Investment Company's portfolio value fell 54% quarter-over-quarter to $71.8M.

Based on AJU IB Investment Company's 13F filing for Q4 2021, filed 9 Feb 2022.